Abstract

ABSTRACTThe purpose of this study was to investigate the in vivo biocompatibility of a new composite made from collagen and liposomes coated with plant derived polysaccharide using a rat subcutaneous implantation model. Histological observation has shown that after five days post-implantation, granulation tissue with vascular dilatation and inflammatory cell infiltration was formed adjacent to the implanted scaffold. After two weeks post-implantation, scaffold was highly infiltrated with cells and many of multinucleated giant cells were found to be aligned along the implant/tissue interface. At four weeks the scaffold was completely infiltrated with cells and a fibrous connective capsule isolate the implanted scaffold from the surrounding tissue. The inflammatory response to the implanted scaffold was assessed by immunohistochemical staining for interleukin 1β. IL-1β was demonstrated early in the post-implantation period (five days), but after two weeks, the intensity of IL-1β staining was on the decline. In vivo studies based on histological and immunohistochemical observations showed that throughout the period of implantation, composite scaffold was well tolerated by the host animals and immune responses to the implant were moderate. The observations are consistent with the normal wound healing response to subcutaneous implantation of biomaterials. The results from the in vivo study indicate a good biocompatibility for porous scaffold made from collagen and liposomes coated with plant derived polysaccharide.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call